iShares U.S. Pharmaceuticals ETF (IHE)

170.69
Delayed Data
As of May 01
 +2.73 / +1.63%
Today’s Change
124.79
Today|||52-Week Range
182.12
+12.74%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.

Performance

1 month+0.04% 3 years+28.64%
3 months+10.66% 5 years+25.49%
1 year+33.22% Since inception+16.25%
Data through 05/02/2015

Quote Details

Previous close$167.96
Open day’s range168.95 – 170.80
Net asset value (NAV)170.83 (05/01/2015)
Daily volume52,208
Average volume (3 months)60,995
Data as of 4:00pm ET, 05/01/2015

Peer Comparisonvs. Health ETFs

 IHECategory
Performance 5-yr return+25.49%+22.89%
Expense Gross exp ratio0.45%0.47%
Risk 5 year sharpe ratio1.841.48
Net assets$1.1B$1.8B
Average market cap$23.0B$35.3B
Average P/E25.025.2
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson9.76%
PFE Pfizer8.83%
MRK Merck7.91%
ACT Actavis6.88%
BMY Bristol-Myers Squibb6.55%
LLY Eli Lilly and Co5.84%
PRGO Perrigo Company PLC3.71%
ZTS Zoetis Inc3.69%
MYL Mylan NV3.59%
ENDP Endo International PLC3.20%

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers